Resultados de la búsqueda 1391-1400 of 18434 for prostate cancer
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To Detect Pancreatic Cancer Using Circulating Tumor ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...
Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology. 2015;86:824. Abdul-Muhsin H, et al ...
The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might affect the ...
Cryotherapy and other ablative techniques for the initial treatment of prostate cancer. https://www.uptodate.com/contents/search. Accessed Oct. 31, 2024 ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
American Cancer Society. https://www.cancer.org ... cancer/ejaculation-and-treatment.html. ... prostate for the treatment of benign prostatic hyperplasia.
The purpose of this study is to collect blood and tissue samples from patients with and without cancer to evaluate laboratory tests for early cancer detection ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?